Distant metastasis after radical prostatectomy in patients without an elevated serum prostate specific antigen level
Open Access
- 15 December 1995
- Vol. 76 (12), 2530-2534
- https://doi.org/10.1002/1097-0142(19951215)76:12<2530::aid-cncr2820761219>3.0.co;2-f
Abstract
Background. Serum prostate specific antigen (PSA) is a sensitive indicator of prostate cancer recurrence after radical prostatectomy. Prostate cancer rarely recurs after radical surgery without PSA elevation. Of the few patients noted in the literature who had a recurrence of cancer without PSA elevation, all had local recurrence alone, except for one, who had bone metastases. Methods. In the authors' series of 628 patients, PSA was the first indicator of recurrence in all but 2 (2.6%) of 77 patients with clinical T1‐T3NxM0 classification prostate cancer. Results. Two of our patients, despite having undetectable PSA levels, had distant recurrence, including one with multiple visceral (lung and brain) metastases. Conclusions. These two cases demonstrate that although uncommon, prostate cancer can recur and metastasize after radical prostatectomy without an increase in the serum PSA level.Keywords
This publication has 24 references indexed in Scilit:
- Prostate Specific Antigen and Gleason Grade: An Immunohistochemical Study of Prostate CancerJournal of Urology, 1994
- SERUM PSA AFTER ANATOMIC RADICAL PROSTATECTOMYUrologic Clinics of North America, 1993
- The Value of Prostate Specific Antigen and Transrectal Ultrasound Guided Biopsy in Detecting Prostatic Fossa Recurrences Following Radical ProstatectomyJournal of Urology, 1993
- Recurrent Prostate Cancer Despite Undetectable Prostate Specific AntigenJournal of Urology, 1992
- Prostate Specific Antigen in Hormonally Treated Stage D2 Prostate Cancer: Is it always an Accurate Indicator of Disease Status?Journal of Urology, 1991
- Editorial CommentsJournal of Urology, 1991
- Prostate Specific Antigen: Not Detectable Despite Tumor Progression after Radical ProstatectomyJournal of Urology, 1989
- Clinical use of Prostate Specific Antigen in Patients with Prostate CancerJournal of Urology, 1989
- Prostate Specific Antigen in the Diagnosis and Treatment of Adenocarcinoma of the Prostate. II. Radical Prostatectomy Treated PatientsJournal of Urology, 1989
- Prostatic Specific Antigen and Prostatic Acid Phosphatase in the Monitoring and Staging of Patients with Prostatic CancerJournal of Urology, 1987